site stats

Stilla technologies malaysia

WebStilla Technologies The naica® system is an easy-to-use dPCR platform that harnesses cutting-edge microfluidic technology to integrate the dPCR workflow onto a single … WebMar 26, 2014 · Almost three years after opening our first Solution Center, we recently opened the 15 th in Sao Paulo, Brazil. This is the second center to be opened in the Latin America region (we opened a center in Mexico City in May) and we are excited that we can now support even more of our customers and partners in the region.These Solution Centers …

Stilla Technologies Appoints Yvan Sergeant as VP citybiz

WebAug 2, 2024 · Stilla Technologies Solidifies Leadership in EMEA, Expands Footprint in APAC August 2, 2024, 9:07 AM · 3 min read PARIS & BOSTON, August 02, 2024 -- ( BUSINESS WIRE )--Stilla Technologies,... WebStilla Technologies is excited to partner with a growing list of distribution partners in order to bring digital PCR and the naica ® system into the laboratories of researchers all across … pollen 23111 https://vapourproductions.com

Péguy CHERY - Regional Marketing Manager - Stilla Technologies

WebRequest a Quote Stilla Technologies Request a Quote Request a Quote Get started with Crystal Digital PCR™ today To hear more about pricing or to request a quote, please fill out the form below, and a Stilla representative will be in touch with you shortly. " * " indicates required fields Name * First Last Email * Institution * Country * State * WebApr 3, 2024 · Stilla Technologies and Atila BioSystems said on Thursday that they will codevelop digital PCR kits for cancer liquid biopsy applications. The firms will jointly market digital PCR kits and assays produced by Atila for use on Stilla's six-color Naica system. The research-use-only kits will be for the detection of circulating tumor DNA from ... WebStilla Technologies has raised a total of €67.2M in funding over 4 rounds. Their latest funding was raised on Nov 23, 2024 from a Debt Financing round. Stilla Technologies is funded by 11 investors. Tusholdings and European Investment Bank are the most recent investors. Funding Rounds Number of Funding Rounds 4 Total Funding Amount €67.2M pollen 22204

Stilla Technologies and Atila BioSystems to Co-Develop High-Plex Digit…

Category:Stilla Technologies LinkedIn

Tags:Stilla technologies malaysia

Stilla technologies malaysia

Request a Quote Stilla Technologies

WebStilla Technologies is committed to improve health by offering a wide range of genetic tests and molecular biology assays – including, but not limited to, liquid biopsy tests for cancer... WebMar 30, 2024 · BOSTON--(BUSINESS WIRE)-- Stilla Technologies and Atila BioSystems today announced an agreement to market digital PCR kits and assays produced by Atila BioSystems for use on the naica® system (Stilla Technologies).The digital PCR kits, optimized specifically for use with the 6-color naica® system, will be utilized for the …

Stilla technologies malaysia

Did you know?

WebNov 20, 2024 · Stilla Technologies will be presenting its latest products and developments in the field of digital PCR at the upcoming annual 4BIO Summit – Europe in Rotterdam, Netherlands on the 27 th and 28 ... WebStilla’s next-generation Multiplex Crystal Digital PCR™ technology employs cutting-edge microfluidic innovations and integrates the entire dPCR process on a single chip. The …

WebApr 5, 2024 · Stilla Technologies has 5 employees across 2 locations and $40.1 m in total funding,. See insights on Stilla Technologies including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. WebStilla Technologies is excited to partner with a growing list of distribution partners in order to bring digital PCR and the naica ® system into the laboratories of researchers all across the globe. Europe and Middle East Country: Bahrain Distribution Partner: Zahrawi Group Visit website Country: Bulgaria Distribution Partner: Ridacom Visit website

WebApr 4, 2024 · “Among digital PCR instruments, Stilla’s naica system offers the industry’s highest level of multiplexing and sensitivity, making the platform ideally suited to detect rare mutations in complex samples,” says Youxiang Wang, PhD, CEO at Atila BioSystems.

WebApr 5, 2024 · About Stilla Technologies Stilla Technologies is the multiplex digital PCR company transforming complex genomic data into actionable insights across a wide range of research and clinical applications including cancer and liquid biopsy studies, cell and gene therapies, infectious disease detection, and food and environmental testing.

WebStilla Technologies is a Paris-based Biotechnology company focusing on developing next-generation genetic tests in Life Science research, from diagnostics and therapeutics to … pollen 22201WebOct 10, 2024 · BEVERLY, Mass., Oct. 10, 2024 /PRNewswire/ -- Stilla Technologies, the provider of pioneering digital PCR (dPCR) solutions for high-precision genetic analysis, announced today that it is ... pollen 23233WebCompany profile page for Stilla Technologies SAS including stock price, company news, press releases, executives, board members, and contact information ... Malaysia Warns People May Deplete ... pollen 30504WebNov 20, 2024 · Stilla Technologies completes €16 Million ($18 Million) Series A financing to commercialize its novel digital PCR system and develop clinical applications USA - … pollen 24012WebStilla Technologies is a Paris-based Biotechnology company focusing on developing next-generation genetic tests in Life Science research, from diagnostics and therapeutics to ‘omics’. We use a ground-breaking integrated digital PCR (dPCR) solution, the Naica System™. Based on a cutting-edge microfluidic technique, superior precision, and ... pollen 30041WebOct 15, 2024 · Stilla Technologies is the multiplex digital PCR company transforming complex genomic data into actionable insights across a wide range of research and clinical applications including cancer... pollen 32162WebApr 6, 2024 · Stilla Technologies is the multiplex digital PCR company transforming complex genomic data into actionable insights across a wide range of research and clinical applications including cancer and liquid biopsy studies, cell and gene therapies, infectious disease detection, and food and environmental testing. pollen 32073